Advertisement
http://www.onyx-pharm.com/wt/page/event_calendar
It is recommended that listeners log on 15 minutes early in order toregister and download any necessary software. For those unable to participateduring the live webcast, a recorded replay of the presentation will beavailable within 24 hours of the completion of the presentation through July26, 2008.
Advertisement
Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed toimproving the lives of people with cancer by changing the way cancer istreated(TM). The company, in collaboration with Bayer HealthCarePharmaceuticals, Inc., is developing and marketing Nexavar(R), a smallmolecule drug. Nexavar is currently approved for the treatment of livercancer and advanced kidney cancer. Additionally, Nexavar is beinginvestigated in several ongoing trials in non-small cell lung cancer,melanoma, breast cancer, and other cancers. For more information about Onyx,visit the company's website at http://www.onyx-pharm.com.
Nexavar(R) (sorafenib) tablets is a registered trademark of BayerPharmaceuticals Corporation.
SOURCE Onyx Pharmaceuticals, Inc.
